Trial Details
COMPLETEDBasic Information
| Clinical ID | c1585 |
|---|---|
| Identifier | NCT03482648 |
| Trial Title | First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: BBT-401-1S, Single dose|DRUG: BBT-401-1S, Multiple doses|DRUG: Placebo |
Participant Information
| Sponsor | Bridge Biotherapeutics, Inc. |
|---|---|
| City | Lincoln |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-03-20 |
|---|---|
| Primary Completion Date | 2018-09-26 |
| Completion Date | 2018-10-03 |